Covered recipient · General Payments record
DINA MALAK MOURICE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$3,762.90
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $989.99 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $282.10 | 5 |
| ABBVIE INC. | $267.75 | 11 |
| Amgen Inc. | $180.33 | 3 |
| PFIZER INC. | $105.26 | 2 |
| Novo Nordisk AS | $104.20 | 5 |
| Astellas Pharma US Inc | $19.28 | 1 |
| Lilly USA, LLC | $17.93 | 1 |
| Dynavax Technologies Corporation | $13.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.62 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107323690 | CMS |
| ABBVIE INC. | $116.48 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107323692 | CMS |
| ABBVIE INC. | $8.46 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107323694 | CMS |
| ABBVIE INC. | $15.59 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107323696 | CMS |
| ABBVIE INC. | $12.69 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107323698 | CMS |
| ABBVIE INC. | $29.23 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107323700 | CMS |
| ABBVIE INC. | $8.69 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107323702 | CMS |
| ABBVIE INC. | $23.78 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107323704 | CMS |
| ABBVIE INC. | $24.04 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107323706 | CMS |
| ABBVIE INC. | $11.26 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107323708 | CMS |
| ABBVIE INC. | $9.91 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107323710 | CMS |
| Amgen Inc. | $16.94 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117635245 | CMS |
| Amgen Inc. | $139.44 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115948816 | CMS |
| Amgen Inc. | $23.95 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115948810 | CMS |
| Astellas Pharma US Inc | $19.28 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139484922 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.18 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104475316 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.55 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105615057 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.68 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104711487 | CMS |
| AstraZeneca Pharmaceuticals LP | $6.51 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104682591 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.18 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104348384 | CMS |
| Dynavax Technologies Corporation | $13.14 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082150367 | CMS |
| Lilly USA, LLC | $17.93 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135611385 | CMS |
| Novo Nordisk Inc | $18.77 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100609050 | CMS |
| Novo Nordisk Inc | $18.97 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100394290 | CMS |
| Novo Nordisk Inc | $20.97 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100511141 | CMS |
| Novo Nordisk Inc | $23.69 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100657059 | CMS |
| Novo Nordisk Inc | $21.80 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100629412 | CMS |
| PFIZER INC. | $18.83 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132066919 | CMS |
| PFIZER INC. | $86.43 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132064112 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.